Efficacy and Renal Safety of Dapagliflozin in Patients with Type 2 Diabetes Mellitus Also Receiving Metformin: A Real-Life Experience.

Alessandro ScorsoneGabriella SauraMattia FleresLucia SpanoVito AielloDavide BrancatoAnna Di NotoFrancesca ProvenzanoVincenzo Provenzano

Published in: Journal of diabetes research (2018)

Dapagliflozin is effective and safe in patients with T2D also receiving metformin. Glycemic control was already achieved with dapagliflozin + metformin, and add-on therapy was not associated with further improvements.

Keyphrases

glycemic control
type diabetes
blood glucose
insulin resistance
metabolic syndrome
cell therapy